Solventum (SOLV) Gains from Investment Securities (2025 - 2026)

Solventum (SOLV) reported Gains from Investment Securities of -$7.0 million for Q1 2026, down 240.0% on a YoY basis from $5.0 million in Q1 2025, and down 216.67% quarter-over-quarter from $6.0 million in Q4 2025.

Solventum (SOLV) Gains from Investment Securities (2025 - 2026) Analysis & Trends

Solventum has reported Gains from Investment Securities for 2 years, with the latest figure at -$7.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Investment Securities fell 240.0% year-over-year to -$7.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (up 20.0% YoY), and the FY2025 full-year result was $18.0 million, changed N/A from the prior year.
  • Gains from Investment Securities for Q1 2026 stood at -$7.0 million, down from $6.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $7.0 million in Q3 2025, with the low at -$7.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.00 Mn
Mar 31, 2026 -7.00 Mn
Dec 31, 2025 6.00 Mn
Dec 31, 2025 6.00 Mn
Sep 30, 2025 7.00 Mn
Sep 30, 2025 7.00 Mn
Mar 31, 2025 5.00 Mn
Mar 31, 2025 5.00 Mn